A B-cell lymphoma case with increased ADA and ACE levels in pleural effusion

P. Arbak, C. Bilgin, O. Balbay, A. N. Annakkaya, E. Gulec, A. Aksoy (Duzce, Turkey)

Source: Annual Congress 2005 - Malignant pleural disease
Session: Malignant pleural disease
Session type: Thematic Poster Session
Number: 570
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Arbak, C. Bilgin, O. Balbay, A. N. Annakkaya, E. Gulec, A. Aksoy (Duzce, Turkey). A B-cell lymphoma case with increased ADA and ACE levels in pleural effusion. Eur Respir J 2005; 26: Suppl. 49, 570

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?
Source: Eur Respir J 2006; 28: Suppl. 50, 783s
Year: 2006

Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

Combined use of pleural fluid adenosine deaminase and lymphocyte/neutrophil ratio for the diagnosis of tuberculous pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 33s
Year: 2004

Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

Interleukin-16 in tuberculous and malignant pleural effusions
Source: Eur Respir J 2005; 25: 605-611
Year: 2005



Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Diagnostic implications of telomerase activity in pleural effusions
Source: Eur Respir J 2003; 22: 422-426
Year: 2003



Is it important to determine pleural fluid amylase in patients with malignant pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007

Value of chitotriosidase enzyme activity in discrimination of tuberculous pleurisy from malignant pleural effusion
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010

Pleural adenosine deaminase determination combined with differential cell counts for early discrimination of exudative pleural effusion in children
Source: Eur Respir J 2004; 24: Suppl. 48, 715s
Year: 2004

Measurement of pleural fluid lactate dehydrogenase and adenosine deaminase for distinguishing malignant pleural effusions and other exudative pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004

Analysis of T-cell subsets in patients with tuberculous pleural effusions
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005


Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003

Pleural effusion adenosine deaminase (ADA) level in patients with tuberculous pleurisy
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010

C-reactive protein in differentiation between tuberculous and malignant pleural effusions
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

LSC Abstract – A requirement for mast cells in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015